Evidence mapPaperPMID 39598449Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Complexity of the Therapeutic Regimen in Older Adults with Cancer: Associated Factors.

Rita F Oliveira, Ana I Oliveira, Agostinho Cruz, Oscar Ribeiro, Vera Afreixo, Francisco Pimentel

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rita F OliveiraREQUIMTE/LAQV, ESS, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal.ORCID 0000-0003-3933-5740
Ana I OliveiraREQUIMTE/LAQV, ESS, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal.ORCID 0000-0003-4420-6476
Agostinho CruzREQUIMTE/LAQV, ESS, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal.ORCID 0000-0002-1157-8196
Oscar RibeiroCenter for Health Technology and Services Research at the Associate Laboratory RISE-Health Research Network (CINTESIS@RISE), Department of Education and Psychology, University of Aveiro (UA), 3810-193 Aveiro, Portugal.ORCID 0000-0003-4740-7951
Vera AfreixoCenter for Research and Development in Mathematics and Applications (CIDMA), Department of Mathematics, University of Aveiro (UA), 3810-193 Aveiro, Portugal.ORCID 0000-0003-1051-8084
Francisco PimentelBlueClinical, 4460-439 Matosinhos, Portugal.ORCID 0000-0001-5993-5132

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesPopulation aging is a worldwide phenomenon and is often associated with multimorbidity and polypharmacy. Complex medication regimens are common among older adults and contribute to the occurrence of harmful health outcomes. Age is one of the main risk factors for cancer. This study aimed to determine and characterize the therapeutic complexity in older patients with cancer, and analyze the factors associated with high complexity and the impact of the oncological context.

methodsA cross-sectional study with patients aged ≥65 years with cancer was conducted in three hospitals in northern Portugal. Data collection was obtained using self-reports. The medication regimen complexity was assessed using the Medication Regimen Complexity Index (MRCI). Descriptive and association statistical analysis were performed. Logistic, linear, simple and multiple regression analysis were conducted, with and without automatic variable selection.

resultsA total of 552 patients were included (median age, 71; IQR, 68-76). The mean MRCI before the oncological context was 18.67 (SD 12.60) and 27.39 (SD 16.67) after the oncological context, presenting a statistically significant difference in the values obtained (

conclusionsThis study demonstrated the existence of high therapeutic complexity in older patients with cancer, suggesting the need for intervention to prevent medication-related problems in this vulnerable population.

Indexed as

agingcancerMedication Regimen Complexity IndexMRCIolder adultspolypharmacy

Identifiers

PMID39598449
PMCPMC11597645

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.